COVID Vaccine Giant AstraZeneca Stock Jumps 7%. What's Behind It?

AstraZeneca Q3 earnings beat forecasts as the drugmaker launches a $1.5 billion savings plan to fund its AI-backed pipeline. The post COVID Vaccine Giant AstraZeneca Stock Jumps 7%. What's Behind It? appeared first on BeInCrypto.